Tech Company Inital Public Offerings
Biodel IPO
Biodel, operating out of Danbury, debuted as a public company on 2/7/2008.
Transaction Overview
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
100 Saw Mill Rd.
Danbury, CT 06810
USA
Danbury, CT 06810
USA
Phone
Website
Email Address
Overview
Biodel Inc. is a specialty pharmaceutical company that develops novel formulations of FDA approved therapeutics to treat endocrine disorders such as diabetes. Biodel's products are created by utilizing the company's proprietary VIAdel technology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Solomon Steiner
Chief Financial Officer
Gerard Michel
Chief Medical Officer
Alan Krasner
Browse more venture capital transactions:
Prev: 2/7/2008: SmartShoot venture capital transaction
Next: 2/7/2008: Cequent Pharmaceuticals venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We report on every notable VC transaction. VC investment data records reported here come from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs